In a previous study, carvacrol ameliorated LPS-induced depression and anxiety-like behavior by regulating the neuroprotective properties of endogenous antioxidant protein Nrf2 (Naeem et al., 2021). The gene discussed is NFE2L2; the disease is major depressive disorder.